GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MeiraGTx Holdings PLC (FRA:328) » Definitions » Total Receivables

MeiraGTx Holdings (FRA:328) Total Receivables : €10.15 Mil (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is MeiraGTx Holdings Total Receivables?

MeiraGTx Holdings's Total Receivables for the quarter that ended in Dec. 2024 was €10.15 Mil.


MeiraGTx Holdings Total Receivables Historical Data

The historical data trend for MeiraGTx Holdings's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MeiraGTx Holdings Total Receivables Chart

MeiraGTx Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Receivables
Get a 7-Day Free Trial Premium Member Only 42.26 30.99 27.40 21.47 10.15

MeiraGTx Holdings Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.47 22.16 4.82 7.60 10.15

MeiraGTx Holdings Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


MeiraGTx Holdings Total Receivables Related Terms

Thank you for viewing the detailed overview of MeiraGTx Holdings's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


MeiraGTx Holdings Business Description

Traded in Other Exchanges
Address
450 East 29th Street, 14th Floor, New York, NY, USA, 10016
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

MeiraGTx Holdings Headlines

No Headlines